亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Expert guidance: Marco Metra named as inaugural editor in chief of the Journal of Valvular and Structural Heart Disease ( EHJ-VSHD )

医学 主编 普通外科 管理 梅德林 临床心脏病学 图书馆学 瓣膜性心脏病 验光服务 医学物理学
作者
Judith Ozkan
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:46 (48): 5217-5218
标识
DOI:10.1093/eurheartj/ehaf748
摘要

All correspondence relating to this paper should be sent to: [email protected] As the new editor in chief (EiC) of the European Heart Journal—Valvular and Structural Heart Disease (EHJ-VSHD), Marco Metra is uniquely placed to advance the journal’s mission. Prof. Metra brings decades of clinical research and experience to the task of disseminating cutting-edge knowledge and science. He is currently the director of the Institute of Cardiology at the Civil Hospital and University of Brescia, Italy, and takes up a senior clinical academic role at the Vita-Salute University, San Raffaele Hospital in Milan, Italy, as of October 2025 (Figure 1). Prof. Marco Metra, MD, new editor in chief of the Journal of Valvular and Structural Heart Disease (EHJ-VSHD) The new journal—launched to address a growing trend in cardiology—was officially unveiled in Madrid, Spain, at the 2025 European Society of Cardiology (ESC) Congress. The impetus for the new publication, Prof. Metra says, came from his previous experience as EiC of the European Journal of Heart Failure (EJHF) between 2015 and 2023. ‘During those years, I noticed a rise in submissions related to valvular and structural heart disease. The focus of many of these articles was not necessarily directly related to heart failure, but to its cause, diagnosis, prognosis, and treatment. I became convinced that these were major areas of interest and it was time to give them their own journal.’ Prof. Metra’s main scientific focus has always been on heart failure which he first encountered when investigating cardiopulmonary exercise testing, followed by beta-blocker therapy and then acute heart failure. He has participated in and coordinated single- and multicentre trials of beta-blocker therapies, as well as the treatment of acute heart failure. More recently, he realized that a major change in the epidemiology of heart failure had taken place. ‘While heart failure was once primarily caused by coronary artery disease and heart attacks, now with improved acute coronary care and an ageing population, we have a situation that has made valvular heart disease a major contributor to heart failure,’ he says. He also notes that transcatheter treatment of valvular heart disease and progress in diagnosis and medical therapy of cardiomyopathies have opened up new indications for patients previously left with no treatment options. The changing epidemiology of heart failure also reflects improved diagnostics that now identify more cardiomyopathy patients, particularly those with cardiac amyloidosis. As major diagnostic and therapeutic advances are now available for both amyloidosis and hypertrophic cardiomyopathy, he says that the field needs to evolve with a focus on cardiovascular therapy moving towards personalised medicine. Prof. Metra describes his time as EiC of the EJHF as among the most satisfying and rewarding periods of his academic career. During this time, the journal became ranked among the top publications for cardiovascular disease. His tenure coincided with the COVID-19 pandemic—a testing time for scientific journals that had to respond with accuracy and clarity to an unprecedented global challenge. This critical event, he says, required leadership and scientific excellence such as that demonstrated by the EJHF, which published early authoritative papers on heart failure and hospitalisations that occurred during the pandemic. He believes this was a major achievement and reflects the duty of an EiC to identify major areas of interest, publish articles that become the reference for others, and anticipate changes ahead of everyone else. The time is now right for a new journal to tackle valvular and structural heart disease, Prof. Metra feels. ‘Our journal will remain focused on these diseases, including their epidemiology, pathophysiology, diagnosis and therapy, rather than on technical aspects and/or their late manifestations, such as arrhythmias or heart failure. Maybe in the near future we will be able to prevent the development of valvular heart disease with specific medications and our journal may be among the first to publish these data. We aim not only to look beyond, but also prior to, the indications and effects of interventional therapies, a hugely progressing field in cardiology. When you have a therapy and something to propose to the patient, there is always an increase in interest about the condition.’ The new journal will focus on three main areas: valvular heart disease, including aortic, mitral, and tricuspid valves; adult congenital heart disease; and remaining structural heart diseases, including amyloid cardiomyopathy, hypertrophic cardiomyopathy, and conditions such as patent foramen ovale, or left atrial auricular thrombosis. Some of these conditions, such as grown-up congenital heart disease, have become major epidemiological problems, but are nevertheless underrepresented in the current literature. He believes that the rise of new diagnostic tools and new treatment options—either medical therapy or transcatheter treatment—has prompted an impressive rise in translational and clinical research with lots of data deserving publication. As the author of over 1200 papers, Prof. Metra is well qualified to identify a good manuscript. ‘In general, journals are still ranked by citations of their articles,’ he says. ‘This is measured as their Impact Factor (IF) or similar, and I agree that the IF value of a scientific article can be related to the number of times it is cited.’ As EiC, he enjoys being able to predict the citation potential of an article, but observes there are exceptions to IF metrics. ‘For instance, an article may be so far ahead of its time that it may be more widely cited 5–10 years later.’ Other ways of assessing impact such as the Altmetric Attention Score—alternative metrics that measure the impact of papers on social media, news outlets, and policy are also vital and possibly more important than the scientific impact alone, he says. ‘Additionally, we have introduced so-called “how to” papers to help clinicians handle challenging medical problems. With these articles, the number of downloads may be a more accurate measurement of their impact.’ Prof. Metra believes that topic interest and the relative novelty of the article—coupled with robust methodology and results that support the conclusions—is what matters when ranking the value of a submitted article and taking a decision on its publication. The role of EiC, he says, provides unique opportunities to shape future directions for research and to decide what is important—and what is not—from submitted articles. ‘It gives you the opportunity to build an editorial board, gather a high-ranking scientific community able to discuss the newest advances in research and take the best decisions. Scientific journals are the essence of scientific research, and the editorial board becomes the place where friendship, mutual trust, and authority allow the journal to grow and the possibility to offer our patients better options for their health and well-being.’ All authors declare no disclosure of interest for this contribution.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
害羞语薇完成签到,获得积分10
6秒前
31秒前
47秒前
受伤若男完成签到,获得积分10
51秒前
null的应助被科研通管家采纳,获得10
55秒前
bkagyin的应助被科研通管家采纳,获得10
55秒前
壮观幻波完成签到,获得积分10
56秒前
自律完成签到,获得积分10
59秒前
Lan完成签到 ,获得积分10
1分钟前
阳光幻巧完成签到,获得积分10
1分钟前
无奈的琦完成签到,获得积分10
1分钟前
科研通AI6.2的应助被hyman采纳,获得10
1分钟前
科研通AI6.4的应助被hyman采纳,获得10
1分钟前
1分钟前
1分钟前
lsl完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
DrShiva完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
生动的昊焱完成签到,获得积分10
1分钟前
1分钟前
1分钟前
震动的静芙完成签到,获得积分10
1分钟前
1分钟前
李健的应助被Eva小飞鱼采纳,获得10
1分钟前
2分钟前
2分钟前
2分钟前
纯情的阁发布了新的文献求助10
2分钟前
纯情的阁发布了新的文献求助10
2分钟前
纯情的阁发布了新的文献求助10
2分钟前
2分钟前
2分钟前
纯情的阁发布了新的文献求助10
2分钟前
纯情的阁发布了新的文献求助10
2分钟前
纯情的阁发布了新的文献求助10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158792
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719316
捐赠科研通 7748395
什么是DOI,文献DOI怎么找? 3427099
关于科研通互助平台的介绍 2551987
邀请新用户注册赠送积分活动 2471354